/
/
/

Jenburkt Pharmaceuticals Balance Sheet

Consolidated
Standalone
₹
%

Share Price Live Stats

Open (₹)911.90
Volume (₹)41.00
High (₹)911.90
Upper Circuit1,032.00
Low (₹)895.00
Lower Circuit688.00
Prev Close860.00
52W High (₹)1,317.00
Price900.00
52W Low (₹)848.05

Share Market Cap & Key Ratios Overview

M.Cap (₹)379.54 Cr
Div. Yield (%)2.41
PE Ratio11.56
Debt to Equity0.00
Price to Book2.14
Book Value446.47
EPS (TTM)74.39
Face Value10.00
ROE (%)18.84

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMA-ANSE
DIVISLAB-ANSE
TORNTPHARM-ANSE
LAURUSLABS-ANSE
ZYDUSLIFE-ANSE
DRREDDY-ANSE
CIPLA-ANSE
MANKIND-ANSE
AUROPHARMA-ANSE
LUPIN-ANSE
JENBURPH-BNSE
LTP
1W Low
1W High
Market cap (₹)
1771.95+9 (0.51%)
1720.80
1854.80
4,24,202Cr
10030+375 (3.88%)
9622.85
10035
2,64,141Cr
4635+70.9 (1.55%)
4555
4668.55
1,74,402Cr
2320+75 (3.34%)
2207.10
2442
1,26,811Cr
1239+53 (4.47%)
1184.55
1264.20
1,23,685Cr
1370+31.5 (2.35%)
1337.30
1390.70
1,11,868Cr
1392.2+35.2 (2.59%)
1360.60
1392.20
1,11,650Cr
2477.1+15.9 (0.65%)
2457.35
2527.80
1,02,196Cr
1699+44 (2.66%)
1650.10
1699
96,951Cr
2012+14 (0.70%)
1974.05
2032
91,301Cr
900+34 (3.93%)
848.05
911.90
380Cr

Key Highlights of Jenburkt Pharmaceuticals Ltd Balance Sheet

Jenburkt Pharmaceuticals Ltd balance sheet discloses shareholders' funds of ₹4.41Cr as of 2026-03-31. The company’s equity share capital is at a value of ₹4.41Cr, and the reserves and surplus of the company is ₹192.63Cr.

The company has its non-current liabilities with total liabilities of ₹223.61Cr as of 2026-03-31.

The current liabilities are ₹23.15Cr as of 2026-03-31. At the same time, current assets are ₹95.09Cr as of 2026-03-31.

Key assets on the balance sheet are non-current investments of ₹27.02Cr and tangible assets of ₹19.46Cr, provided in the Jenburkt Pharmaceuticals Ltd financial statements.